FAQ/Help |
Calendar |
Search |
Today's Posts |
|
![]() |
#1 | |||
|
||||
Member
|
This drug got a friend of mine out of wheelchair after taking it 1 1/2 yrs.
He had MS for years, progressed to wheelchair, then hospital bed. Dr. told him "take this" and you'll be out of chair in 1 1/2 yrs. It worked. It dissapeared approx 4 yrs ago. Was originally released for Genatle Herpes Warts. Off label uses are chronic hepatitis c, hairy cell leukemia, malignant melanoma, aids-related Kaposi's disease, bladder cancer, carcinoid syndrome, renal cancer, multiple myeloma, ovarian cancer, ect. Amazing drug that i've also called fda and co on. We both got different answers why it's not available. It's still able to be prescribed. Still in pharmacy's system if you call for price check. Alferon N by Hemispherx. Both our conclusions are it was too good for the money. Remember that name Interferon Alfa-n3. Thankyou |
|||
![]() |
![]() |
"Thanks for this!" says: | SallyC (10-10-2009) |
![]() |
#2 | |||
|
||||
In Remembrance
|
__________________
~Love, Sally . "The best way out is always through". Robert Frost ~If The World Didn't Suck, We Would All Fall Off~ |
|||
![]() |
![]() |
![]() |
#3 | |||
|
||||
Member
|
Thankyou and if it's ok to quote the article which I believe should:
Patients receiving IFN alfa-n3 were significantly younger and had a longer disease duration than the other patients. The MRI lesion loads and EDSS scores were significantly reduced at 1 year in the IFN alfa-n3 vs the untreated group. Median lesion volume change was -7.2% for IFN beta-1b vs +11.7% for untreated patients and -10.4% for patients receiving IFN alfa-n3 (P = .009). Mean EDSS change at 1 year was -0.20 in IFN beta-1b, +0.68 for untreated, and -1.13 for IFN alfa-n3 patients (IFN beta-1b vs untreated, P = .02; IFN alfa-n3 vs untreated, P = .0001). No significant adverse effects were seen in the IFN alfa-n3 group, except for 1 case of deep venous thrombosis. These data should be interpreted with caution, since the study was open-label, retrospective, nonrandomized, and the clinical evaluations were unblinded. However, further study of the efficacy of IFN alfa-n3 in MS is warranted. Dr. Sheremata, the senior author of the study, commented that "follow-up studies are planned" at his comprehensive MS center at the University of Miami. Funny thing..my friend was in a Miami hospital..13? years ago. I didn't see a article date. It performed a miracle on him. I'd like the same. |
|||
![]() |
![]() |
"Thanks for this!" says: | SallyC (10-11-2009) |
![]() |
#4 | |||
|
||||
Grand Magnate
|
I believe it helped your friend, the article is positive but I've never heard of this. Anyone? Any trials ever done? Any European info?
__________________
Kicker PPMS, DXed 2002 Queen of Maryland Wise Elder no matter what my count is. |
|||
![]() |
![]() |
![]() |
#5 | |||
|
||||
Grand Magnate
|
Did a little research - seems most recent I could find was '04 info. I'm not very good at understanding info, there are others good at this but IMHO Interferon A is a more tolerated form of Interferon than B which some can not take? Anyone really know? Sounds RR, me being PP I know it would never help me.
__________________
Kicker PPMS, DXed 2002 Queen of Maryland Wise Elder no matter what my count is. |
|||
![]() |
![]() |
![]() |
#6 | |||
|
||||
Member
|
http://www.biospace.com/news_story.a...ityId=15487620
Article states all worldwide rights were bought by co. March 2004. They mightve sold off the remaining stock acquired from last co. and then quit. Doesnt make sense to buy rights and not produce. Fishy. |
|||
![]() |
![]() |
"Thanks for this!" says: | SallyC (10-16-2009) |
Reply |
|
|
![]() |
||||
Thread | Forum | |||
Interferon Therapy | Multiple Sclerosis | |||
New Interferon Formulations Promise to Eliminate Injections in Multiple Sclerosis Tre | Multiple Sclerosis | |||
Effects from long term interferon use? | Multiple Sclerosis |